2004 Archive

November 10, 2004
Data Presented at AHA Scientific Sessions 2004 Demonstrate Elevated Lp-PLA2 Levels Predict Coronary Artery Disease
Second Study Highlights Specificity of the PLAC® Test in Measuring Inflammation

November 9, 2004
Elevated Inflammatory Enzyme, Lp-PLA2, Significantly Linked to Ischemic Stroke

November 9, 2004
Study Highlights the Role of Lp-PLA2 and Inflammation in the Formation of Vulnerable PLAque - A Major Cause of Heart Attack And Stroke

October 25, 2004
diaDexus Announces Presentations Highlighting the Role of Lp-PLA2 in Cardiovascular Disease and Stroke at the American Heart Association Scientific Sessions 2004

October 25, 2004
diaDexus to Present at Rodman & Renshaw Techvest 6th Annual Healthcare Conference

October 5, 2004
Results From Landmark 14-Year Study Show Lp-PLA2 is Independent Predictor of Coronary Events

September 29, 2004
New Website Exposes Hidden Risk Factors for Heart Disease and What You Can Do About Them

September 16, 2004
Medarex and diaDexus Expand Collaboration for Development of Fully Human Antibody Therapeutics for the Treatment of Cancer

August 31, 2004
diaDexus Study Shows Lp-PLA2 to be an Independent Risk Marker for Coronary Artery Disease

August 31, 2004
New Study Shows Elevation in Enzyme Tied to Higher Cardiovascular Risk

July 22, 2004
diaDexus Partners with ARUP Laboratories to Make Novel PLAC® Test Available to Measure Increased Risk for Coronary Heart Disease

May 10, 2004
diaDexus Presents at Rodman & Renshaw Techvest Global Healthcare Conference

May 8, 2004
Novel Cardiovascular Marker Predicts Risk of Stroke
New data show individuals with highest Lp-PLA2 levels are at 2-fold higher risk

March 26, 2004
diaDexus Announces Scientific Presentations at AACR
Studies of Novel Markers in Ovarian, Prostate and Lung Cancer

February 2, 2004
Lp-PLA2 Predicts Coronary Heart Disease
Study of the ARIC Population Published in Circulation

January 6, 2004
diaDexus Appoints John Keller, Ph.D., to Board of Directors